Biotechnology

Filter

Current filters:

None

Popular Filters

64 to 88 of 2444 results

Government action needed to slash prices for hepatitis C treatments, says US advocacy

Government action needed to slash prices for hepatitis C treatments, says US advocacy

04-12-2014

The US federal government should act to dramatically lower the cost of new and prohibitively pricey medications…

Anti-viralsBiotechnologyGilead SciencesPricingSovaldiUSA

Array BioPharma to regain global rights to binimetinib from Novartis

04-12-2014

Shares of US biotech firm Array BioPharma leapt 22.8% to $4.80 in after-hours trading on Wednesday, after…

Array BioPharmabinimetinibBiotechnologyGlobalLicensingNovartisOncology

US FDA grants earlier approval for Amgen’s Blincyto for rare form of lymphoblastic leukemia

US FDA grants earlier approval for Amgen’s Blincyto for rare form of lymphoblastic leukemia

04-12-2014

Ahead of the anticipated decision date, the US Food and Drug Administration yesterday approved Blincyto…

AmgenBiotechnologyblinatumomabBlincytoOncologyRegulationUSA

Lilly in-licenses Zosano’s osteo patch for up to $440 million

03-12-2014

Privately-held US biotech firm Zosano Pharma has entered into an exclusive agreement with pharma major…

Anti-Arthritics/RheumaticsBiotechnologyEli LillyLicensingZosano PharmaZP-PTH

Puma shares plummet as it delays NDA filing

Puma shares plummet as it delays NDA filing

03-12-2014

Puma Biotechnology will delay the filing of its New Drug Application (NDA) for the approval of PB272…

BiotechnologyneratinibOncologyPuma BiotechnologyRegulationUSA

Medical Research Council develops XNAzyme, a world-first synthetic enzyme

Medical Research Council develops XNAzyme, a world-first synthetic enzyme

01-12-2014

Scientists from the UK's Medical Research Council have created the world’s first artificial enzymes…

BiotechnologyChemistryGeneticsMedical Research CouncilResearchUK

Spanish physicians’ understanding of biosimilars: ASBM survey

28-11-2014

The Alliance for Safe Biologic Medicines (ASMB) presented results from a survey of European physicians…

BiosimilarsBiotechnologyHealthcareMarkets & MarketingSpain

Cocrystal Pharma and RFS Pharma complete merger

28-11-2014

USA-based biotech firm Cocrystal Pharma has announced the closing of its merger with RFS Pharma, a privately…

Anti-viralsBiotechnologyCocrystal PharmaMergers & AcquisitionsRFS Pharma

A back-to-biology approach to cancer therapies: an interview with Berg's Dr Niven Narain

A back-to-biology approach to cancer therapies: an interview with Berg's Dr Niven Narain

27-11-2014

Massachusetts-based biopharma company Berg is aiming to change the way we treat cancer.

BergBiotechnologyOncologyResearchUSA

NICE final draft guidance recommends Soliris, but saying it is “very expensive”

NICE final draft guidance recommends Soliris, but saying it is “very expensive”

27-11-2014

The UK National Institute for Health and Care Excellence (NICE) has today issued final draft guidance…

Alexion PharmaceuticalsBiotechnologyPricingRare diseasesRegulationSolirisUK

Modern Biosciences announces RA R&D agreement with Janssen Biotech

Modern Biosciences announces RA R&D agreement with Janssen Biotech

27-11-2014

UK-based drug development company Modern Biosciences has entered into an R&D alliance and global option…

Anti-Arthritics/RheumaticsBiotechnologyJanssen BiotechLicensingModern BiosciencesUK

Takeda's Entyvio given provisional approval by UK's NICE

Takeda's Entyvio given provisional approval by UK's NICE

26-11-2014

The UK’s National Institute for Health and Care Excellence (NICE) has given a provisional approval…

BiotechnologyEntyvioGastro-intestinalsRegulationTakeda PharmaceuticalUK

AbbVie acquires API facility in Singapore; Amgen completes new unit

AbbVie acquires API facility in Singapore; Amgen completes new unit

26-11-2014

US pharma major AbbVie has acquired a small-molecule active pharmaceutical ingredient (API) manufacturing…

AbbVieAmgenBiotechnologyGenericsProductionSingapore

Strengthen IP to reposition Australia as a global leader, says Medicines Australia chief to government

Strengthen IP to reposition Australia as a global leader, says Medicines Australia chief to government

26-11-2014

The chief executive of Medicines Australia has called for a strengthening of Australia’s intellectual…

AustraliaBiotechnologyLegalMedicines AustraliaRegulationResearch

Regeneron and Sanofi granted breakthrough designation for dupilumab

Regeneron and Sanofi granted breakthrough designation for dupilumab

25-11-2014

US biotech Regeneron Pharmaceuticals and French pharma major Sanofi have said that the US Food and Drug…

BiotechnologyDermatologicalsdupilumabRegeneronRegulationSanofiUSA

Merck gains rights to NewLink Genetics investigational Ebola vaccine

24-11-2014

US pharma giant Merck & Co has entered into an exclusive worldwide license agreement to research, develop,…

Anti-viralsBiotechnologyGlobalLicensingMerck & CoNewLink GeneticsResearchrVSV-EBOYTropical diseases

Amgen halts all its trials of rilotumumab in advanced gastric cancer

24-11-2014

USA-based Amgen has terminated all company-sponsored clinical studies of rilotumumab in advanced gastric…

AmgenBiotechnologyOncologyResearchrilotumumab

Bristol-Myers Squibb partners with Five Prime on immunotherapy combination trials

Bristol-Myers Squibb partners with Five Prime on immunotherapy combination trials

24-11-2014

US drug major Bristol-Myers Squibb and protein therapeutics specialist Five Prime Therapeutics are to…

BiotechnologyBristol-Myers SquibbFive Prime TherapeuticsOncologyOpdivoResearchUSA

Reasons for Epidermal Growth Factor Receptor failure in liver cancer found by Austrian doctoral program

Reasons for Epidermal Growth Factor Receptor failure in liver cancer found by Austrian doctoral program

24-11-2014

Researchers from the Medical University of Vienna, Austria, have clarified why using therapeutic agents…

AustriaBiotechnologyMedicineOncologyResearch

Positive Ph III results for Relypsa’s patiromer FOS for hyperkalemia

22-11-2014

US biotech firm Relypsa announced that positive results from the pivotal Phase III program of the company's…

BiotechnologyNephrology and HepatologypatiromerRelypsaRenagelRenvelaResearchSanofiZS PharmaZS-9

AstraZeneca to invest $200 million in expanding US biologics manufacturing center

22-11-2014

Anglo-Swedish pharma major AstraZeneca on Friday unveiled plants to expand its biologics manufacturing…

AstraZenecaBiotechnologyFinancialMedImmuneProductionUSA

64 to 88 of 2444 results

Back to top